English 
Stem Cell Research & Therapy
Fueling Stem Cell Breakthroughs
Stem cell research is revolutionizing medicine. Our stable growth factors ensure optimal cell differentiation,
growth, and development, which are critical to the success of stem cell therapies.
growth, and development, which are critical to the success of stem cell therapies.
Key Proteins We Offer
Encourages stem cell proliferation and self-renewal
Directs stem cell differentiation and tissue engineering.
Supports stem cell survival and angiogenesis.
Aids in stem cell adhesion and differentiation.
Scaffold proteins that promote 3D cell cultures.
Application
Stem cell expansion and differentiation protocols.
Regenerative medicine and tissue engineering projects.
Partner with Us
Our proteins enhance the efficacy of stem cell cultures and treatments, fostering the next wave of medical innovations.
We, Genexis Biotech Pvt. Limited have started our journey into the biotechnology sector. Genexis research lab and office are placed in the heart of the beautiful city of Vadodara, Gujarat.
Quick Contact
Plot 86, Brushellz Industrial Park, Opp. GSFC Next to Toyota Showroom, Dashrath, Vadodara Gj 390024 India
We, Genexis Biotech Pvt. Limited have started our journey into the biotechnology sector. Genexis research lab and office are placed in the heart of the beautiful city of Vadodara, Gujarat.
Quick Contact
Plot 86, Brushellz Industrial Park, Opp. GSFC Next to Toyota Showroom, Dashrath, Vadodara - 390024, India
At Genexis Biotech, we’re on a mission to transform biotechnology with purpose and precision. From pioneering animal-free solutions to advancing sustainable innovation, our commitment to a better future drives everything we do.
Join us in building a world where science meets ethics, and progress serves both humanity and the planet. Let’s create a lasting impact—together.
Quick Contact
Plot 86, Brushellz Industrial Park, Opp. GSFC Next to Toyota Showroom, Dashrath, Vadodara - 390024, India
Copyright © 2024 Genexis Biotech. All rights reserved. Developed by Clicks Media
